What does FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE do?

FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE is a specialist medical practice in Gent. Private Limited, started on 1 March 1989, 2 establishments.

What is the address of FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE?

The registered office of FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE is located at Vrijheidslaan 5, 9000 Gent.

Is FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE still active?

Yes. According to the CBE (31 October 2026) FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE is active, legal situation “Normale toestand”, started on 1 March 1989.

Is FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE registered on Peppol?

No, FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE is currently not registered on the Peppol network.

What is the enterprise number of FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE?

The enterprise number of FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE is BE0436909477.

When was FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE founded?

FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE was founded on 1 March 1989.

Who are the directors of FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE?

According to the 2024 annual accounts, the directors of FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE are: Jan Bonte.

Is FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 March 1989; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE make in 2024?

FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE posted a profit after taxes of € 9,513 in financial year 2024.

What is the revenue of FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE?

As a small company, FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 60,654.

FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE (Private Limited)

Dossier FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE, printed on 31 October 2026 from databakkes.be/en/0436909477/fysische-geneeskunde-en-revalidatie-dr-bonte. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 27 % of short-term debt in 2024; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE from Gent, company number BE0436909477, closed financial year 2024 with a result of € 9,513 after tax. For that financial year FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE recorded a gross margin of € 60,654 and equity of € 373,396. Compared with financial year 2023, the result moved from € 36,684 to € 9,513. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 28, 2025.

What it is worth Growing

€ 373,396

▲ 3% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 9,513

▼ 74% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 22,179

▼ 4% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 360,996.

People and assets in 2024

Wage cost

€ 9,792

▼ 3% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 86,582

▼ 15% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 113,645

▲ 2% vs 2023

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 2,343

▲ 115% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 2,224

▼ 57% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 79,739 Gross margin 2021: € 79,739 First fiscal year in the series	€ 79,168 Gross margin 2022: € 79,168 ▼ 1% vs 2021 (€ 79,739) Unfavourable step	€ 73,803 Gross margin 2023: € 73,803 ▼ 7% vs 2022 (€ 79,168) Unfavourable step	€ 60,654 Gross margin 2024: € 60,654 ▼ 18% vs 2023 (€ 73,803) Unfavourable step	▼ 18%
Profit after taxes	€ 37,337 Profit after taxes 2021: € 37,337 First fiscal year in the series	€ 37,244 Profit after taxes 2022: € 37,244 Unchanged (€ 37,337) Unfavourable step	€ 36,684 Profit after taxes 2023: € 36,684 ▼ 2% vs 2022 (€ 37,244) Unfavourable step	€ 9,513 Profit after taxes 2024: € 9,513 ▼ 74% vs 2023 (€ 36,684) Unfavourable step	▼ 74%
Equity	€ 289,955 Equity 2021: € 289,955 First fiscal year in the series	€ 327,199 Equity 2022: € 327,199 ▲ 13% vs 2021 (€ 289,955) Favourable step	€ 363,883 Equity 2023: € 363,883 ▲ 11% vs 2022 (€ 327,199) Favourable step	€ 373,396 Equity 2024: € 373,396 ▲ 3% vs 2023 (€ 363,883) Favourable step	▲ 3%
Total debts	€ 214,849 Total debts 2021: € 214,849 First fiscal year in the series	€ 218,650 Total debts 2022: € 218,650 ▲ 2% vs 2021 (€ 214,849) Unfavourable step	€ 227,664 Total debts 2023: € 227,664 ▲ 4% vs 2022 (€ 218,650) Unfavourable step	€ 225,993 Total debts 2024: € 225,993 ▼ 1% vs 2023 (€ 227,664) Favourable step	▼ 1%
Cash	€ 34,741 Cash 2021: € 34,741 First fiscal year in the series	€ 40,017 Cash 2022: € 40,017 ▲ 15% vs 2021 (€ 34,741) Favourable step	€ 23,082 Cash 2023: € 23,082 ▼ 42% vs 2022 (€ 40,017) Unfavourable step	€ 22,179 Cash 2024: € 22,179 ▼ 4% vs 2023 (€ 23,082) Unfavourable step	▼ 4%
Land & buildings	€ 35,325 Land & buildings 2021: € 35,325 First fiscal year in the series	€ 35,325 Land & buildings 2022: € 35,325 Unchanged (€ 35,325) Unchanged	€ 35,325 Land & buildings 2023: € 35,325 Unchanged (€ 35,325) Unchanged	€ 35,325 Land & buildings 2024: € 35,325 Unchanged (€ 35,325) Unchanged
Retained profit	€ 277,555 Retained profit 2021: € 277,555 First fiscal year in the series	€ 314,799 Retained profit 2022: € 314,799 ▲ 13% vs 2021 (€ 277,555) Favourable step	€ 351,483 Retained profit 2023: € 351,483 ▲ 12% vs 2022 (€ 314,799) Favourable step	€ 360,996 Retained profit 2024: € 360,996 ▲ 3% vs 2023 (€ 351,483) Favourable step	▲ 3%
Bank debt	€ 105,736 Bank debt 2021: € 105,736 First fiscal year in the series	€ 108,499 Bank debt 2022: € 108,499 ▲ 3% vs 2021 (€ 105,736) Unfavourable step	€ 111,937 Bank debt 2023: € 111,937 ▲ 3% vs 2022 (€ 108,499) Unfavourable step	€ 113,645 Bank debt 2024: € 113,645 ▲ 2% vs 2023 (€ 111,937) Unfavourable step	▲ 2%
Balance sheet total	€ 504,804 Balance sheet total 2021: € 504,804 First fiscal year in the series	€ 545,849 Balance sheet total 2022: € 545,849 ▲ 8% vs 2021 (€ 504,804) Unchanged	€ 591,547 Balance sheet total 2023: € 591,547 ▲ 8% vs 2022 (€ 545,849) Unchanged	€ 599,389 Balance sheet total 2024: € 599,389 ▲ 1% vs 2023 (€ 591,547) Unchanged	▲ 1%

Key figures of FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE?

What happened at FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 28, 2025 New annual accounts for financial year 2024: profit of € 9,513 (▼ 74% vs 2023). Source: NBB ↗
Jan 1, 2000 New establishment in Gent. KBO
Mar 1, 1989 New establishment in Gent. KBO
Mar 1, 1989 Start of the company according to the CBE. KBO

In short

From € 37,337 profit in 2021 to € 9,513 profit in 2024.

Paid € 65,055 in corporate taxes since 2021.

Best year ever: 2021, with € 37,337 profit.

Original PDFs at the National Bank ↗

Management

Jan Bonte

FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE

Behind FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE is Jan Bonte.

Directors

According to the 2024 annual accounts

Jan Bonte

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Vrijheidslaan 5

9000 Gent

2.328.510.635

Kortrijksesteenweg 686

9000 Gent

Active since 1 January 2000

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

OpenDDP

BM BONTE - GOVAERT

ORTHOLOOK

€ -4,041 gross margin · 2025

Wikifonia

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0436.909.477
VAT number: BE 0436.909.477
Registered office: Vrijheidslaan 5, 9000 Gent
Names & denominations: FYSISCHE GENEESKUNDE EN REVALIDATIE, Dr. BONTE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 March 1989
Peppol: Not registered
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗